Continuous arteriovenous haemofiltration. A new kidney replacement therapy. 1981

P Kramer, and J Schrader, and W Bohnsack, and G Grieben, and H J Gröne, and F Scheler

Twenty intensive care patients, who as an additional complication developed acute oliguric renal failure were treated solely with continuous arteriovenous haemofiltration (CAVH). The mean spontaneous filtration rate was 8.8 +/- 3.5ml/min. IV substitution of the ultrafiltrate by K+-free Ringer's lactate solution resulted in a steady state plasma creatinine level of 6.4 +/- 3.5mg/dl. Duration of treatment was three to 24 days (10.5 +/- 7.9 days). Eight patients recovered kidney function and survived. Clinical experience in five intensive care units with more than 150 applications of CAVH allows the following conclusions: optimal control of water and electrolyte balance; unlimited parenteral nutrition; continuous fluid withdrawal better tolerated than intermittent withdrawal by means of dialysis. With skilled puncture of the femoral artery there was no risk of bleeding. Low dose continuous heparin administration (10IU/kg/hr) into the arterial blood line is sufficient for extracorporeal anticoagulation. Haemofilters can be used for a long time (two to ten days). Specially trained dialysis personnel and investment costs for machines are not necessary.

UI MeSH Term Description Entries
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D001783 Blood Flow Velocity A value equal to the total volume flow divided by the cross-sectional area of the vascular bed. Blood Flow Velocities,Flow Velocities, Blood,Flow Velocity, Blood,Velocities, Blood Flow,Velocity, Blood Flow
D005263 Femoral Artery The main artery of the thigh, a continuation of the external iliac artery. Common Femoral Artery,Arteries, Common Femoral,Arteries, Femoral,Artery, Common Femoral,Artery, Femoral,Common Femoral Arteries,Femoral Arteries,Femoral Arteries, Common,Femoral Artery, Common
D005268 Femoral Vein The vein accompanying the femoral artery in the same sheath; it is a continuation of the popliteal vein and becomes the external iliac vein. Femoral Veins,Vein, Femoral,Veins, Femoral
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014462 Ultrafiltration The separation of particles from a suspension by passage through a filter with very fine pores. In ultrafiltration the separation is accomplished by convective transport; in DIALYSIS separation relies instead upon differential diffusion. Ultrafiltration occurs naturally and is a laboratory procedure. Artificial ultrafiltration of the blood is referred to as HEMOFILTRATION or HEMODIAFILTRATION (if combined with HEMODIALYSIS).
D058186 Acute Kidney Injury Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions. Acute Kidney Failure,Acute Kidney Insufficiency,Acute Renal Failure,Acute Renal Injury,Acute Renal Insufficiency,Kidney Failure, Acute,Kidney Insufficiency, Acute,Renal Failure, Acute,Renal Insufficiency, Acute,Acute Kidney Failures,Acute Kidney Injuries,Acute Kidney Insufficiencies,Acute Renal Failures,Acute Renal Injuries,Acute Renal Insufficiencies,Kidney Failures, Acute,Kidney Injuries, Acute,Kidney Injury, Acute,Kidney Insufficiencies, Acute,Renal Failures, Acute,Renal Injuries, Acute,Renal Injury, Acute,Renal Insufficiencies, Acute

Related Publications

P Kramer, and J Schrader, and W Bohnsack, and G Grieben, and H J Gröne, and F Scheler
September 1994, The Journal of the Association of Physicians of India,
P Kramer, and J Schrader, and W Bohnsack, and G Grieben, and H J Gröne, and F Scheler
January 1985, Contributions to nephrology,
P Kramer, and J Schrader, and W Bohnsack, and G Grieben, and H J Gröne, and F Scheler
June 1993, The Journal of the Association of Physicians of India,
P Kramer, and J Schrader, and W Bohnsack, and G Grieben, and H J Gröne, and F Scheler
January 1989, Intensive care medicine,
P Kramer, and J Schrader, and W Bohnsack, and G Grieben, and H J Gröne, and F Scheler
May 1990, Pediatric nephrology (Berlin, Germany),
P Kramer, and J Schrader, and W Bohnsack, and G Grieben, and H J Gröne, and F Scheler
March 1991, The Journal of antimicrobial chemotherapy,
P Kramer, and J Schrader, and W Bohnsack, and G Grieben, and H J Gröne, and F Scheler
July 1987, The International journal of artificial organs,
P Kramer, and J Schrader, and W Bohnsack, and G Grieben, and H J Gröne, and F Scheler
March 1988, Lancet (London, England),
P Kramer, and J Schrader, and W Bohnsack, and G Grieben, and H J Gröne, and F Scheler
January 1990, Intensive care medicine,
P Kramer, and J Schrader, and W Bohnsack, and G Grieben, and H J Gröne, and F Scheler
June 1994, Pediatric nephrology (Berlin, Germany),
Copied contents to your clipboard!